Becker’s Hospital Review recently honored University of Virginia Medical Center on its list of 100 hospitals and health systems with great neurosurgery and spine programs.
Author: hford (Page 24)
Interventional cardiologist Scott Lim, MD, explains the advantages of the AMPLATZER™ PFO Occluder device, which was recently approved by the FDA and is now available at UVA.
A recipient of the 2016 Rising Star in Oncology award from the Society for Translational Medicine, Reilley has set his sights on improving the future of cancer care through clinical trials.
The evolution of this procedure is a great example of how scientists and physicians can, through collaboration, discovery and determination, transform a miraculous concept into routine practice.
To ensure that children with asthma receive consistent, evidence-based care, the UVA Children’s Hospital has joined a consortium of 89 hospitals in a nationwide effort to decrease the use of unnecessary interventions.
New ACR Appropriateness Criteria added unprecedented depth to what had been a much more modest overview, providing physicians an easy way to catch up with the latest developments and stay at the very forefront of best practices.
Dr. Saavedra specializes in the diagnosis and care of complex medical dermatology, and his clinical interests include HIV dermatology, severe drug reactions that manifest with dermatologic complications, and care of oncologic and post-transplant patients.
Becker's Hospital Review has once again ranked University of Virginia Heart and Vascular Center among the top 100 hospitals and health systems in the country with great heart programs.
The Phase II study has enrolled 120 women ages 45 and older with stage 0 or stage 1 breast cancer. Recruitment is ongoing at UVA and the study is now enrolling participants at Thomas Jefferson University in Philadelphia as well.
Zeiger is one of just 19 women currently leading surgical departments in the United States.